Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
How Much Growth is Expected for the Lung Cancer Diagnostic And Screening Market from 2024 to 2033?
The market size for lung cancer diagnosis and screening has seen a swift expansion in the preceding years. It’s anticipated to rise from $2.11 billion in 2023 to $2.32 billion in 2024, boasting a compound annual growth rate (CAGR) of 10.2%. Factors like the development of digital imaging, standardization of screening methods, public health campaigns against smoking, the creation of cancer registries, and progress in pathology analysis have all significantly contributed to the market’s historic growth.
The size of the lung cancer diagnostic and screening market is anticipated to experience robust growth in the coming years, expanding to $3.3 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. This projected growth during the forecast period can be ascribed to an upward trend in lung cancer cases, an intensified focus on early detection, development of screening programs for high-risk individuals, a shift towards individualized medicine, and government-backed initiatives and funding. The anticipated trends during this period encompass the emergence of new screening methods, progress in biomarker testing, employment of artificial intelligence (AI), increased use of liquid biopsies, emphasis on early stage detection, and an expansion of low-dose ct screening programs.
Claim Your Free Sample of the Global Lung Cancer Diagnostic And Screening Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12043&type=smp
What Factors Are Encouraging Growth in the lung cancer diagnostic and screening Market?
The lung cancer diagnostic and screening market is poised to grow due to the rising occurrence of lung cancer. Lung cancer, a severe disease typified by uncontrolled growth of abnormal cells in lung tissues, exhibits indicators such as coughing, chest pain, and breathing difficulties. Early detection of the disease in affected individuals is possible through lung cancer diagnosis and screening using methods like incisional biopsy and bronchoscopy. As per the American Cancer Society, a US-based government establishment, the US saw an approximate 238,340 new instances of lung cancer in January 2023 (117,550 in men and 120,790 in women). Additionally, lung cancer claimed 127,070 lives (67,160 men and 59,910 women). Consequently, the increase in lung cancer incidence fuels the expansion of the lung cancer diagnostics and screening market.
Which Segments Play a Vital Role in the Lung Cancer Diagnostic And Screening Market?
1) By Product: Instruments, Consumables And Accessories
2) By Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests
3) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
4) By End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users
What Trends Are Driving Change in the Lung Cancer Diagnostic And Screening Market?
The increasing prevalence of technological advancements is a rising trend in the lung cancer diagnostics and screening sector. Leading companies in this field are adopting innovative techniques to maintain market prominence. For example, in December 2021, Auris Health, a U.S.-based medical robotics firm, launched the MONARCH Robotic-Assisted Bronchoscopy procedure, marking the introduction of the first MONARCH procedure. This groundbreaking procedure permits doctors to precisely identify and diagnose minute and challenging-to-access lung nodules, facilitating biopsy and thus, early detection and treatment of lung conditions.
Order Now for Fast Delivery of Your Lung Cancer Diagnostic And Screening Market Report!
What Regions Are Contributing Significantly to the Growth of the Lung Cancer Diagnostic And Screening Market?
North America was the largest region in the lung cancer diagnostic and screening market in 2023. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Lung Cancer Diagnostic And Screening Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the lung cancer diagnostic and screening market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Lung Cancer Diagnostic And Screening Market Include
1. Lung Cancer Diagnostic And Screening Market Executive Summary
2. Lung Cancer Diagnostic And Screening Market Segments
3. Lung Cancer Diagnostic And Screening Market Size And Template Market Growth Rate
4. Key Lung Cancer Diagnostic And Screening Market Trends
5. Major Lung Cancer Diagnostic And Screening Market Drivers
……
25. Key Mergers And Acquisitions In The Lung Cancer Diagnostic And Screening Market
26. Top Lung Cancer Diagnostic And Screening Companies
27. Lung Cancer Diagnostic And Screening Market Opportunities And Strategies
28. Lung Cancer Diagnostic And Screening Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
